Philip J. Moos

Philip J. Moos, PhD

Languages spoken: English

Phillip Moos, PhD, is an assistant professor in the Department of Pharmacology and Toxicology at the University of Utah and a member of the Cell Response and Regulation Program at Huntsman Cancer Institute.

Moos studies the reduction-oxidation relationship between inflammation and cancer. He is particularly interested in the role of selenoproteins in the origin of cancer. He also studies the role of thioredoxin reductase-1 in melanoma, and nanoparticles found in consumer products as potential initiators of inflammatory responses and cancer.

Moos received a bachelor's degree from the University of Colorado, Boulder, and a PhD from Kansas State University.

Education History

Undergraduate University of Colorado
 BS
Graduate Training University of Colorado
 MS
Doctoral Training Kansas State University
 PhD
Postdoctoral Fellowship Kansas State University
 Postdoctoral Fellow
Postdoctoral Fellowship Pharmacia & Upjohn, Inc.
 Postdoctoral Fellow

Selected Publications

Journal Article

  1. Kwon SH, Li L, Terry CM, Shiu YT, Moos PJ, Milash BA, Cheung AK, Blumenthal D (2018). Differential gene expression patterns in vein regions susceptible versus resistant to neointimal hyperplasia. Physiological genomics, 50(8), 615-627.
  2. Piccolo SR, Hoffman LM, Conner T, Shrestha G, Cohen AL, Marks JR, Neumayer LA, Agarwal CA, Beckerle MC, Andrulis IL, Spira AE, Moos PJ, Buys SS, Johnson WE, Bild A (2016). Integrative analyses reveal signaling pathways underlying familial breast cancer susceptibility. Molecular systems biology, 12(3), 860.
  3. Yazdimamaghani M, Moos PJ, Ghandehari (2019). Time- and dose-dependent gene expression analysis of macrophage response as a function of porosity of silica nanoparticles. Nanomedicine, 21, 102041.
  4. Yazdimamaghani M, Moos PJ, Dobrovolskaia MA, Ghandehari (2019). Genotoxicity of amorphous silica nanoparticles: Status and prospects. Nanomedicine, 16, 106-125.
  5. Yazdimamaghani M, Moos PJ, Ghandehari (2018). Global gene expression analysis of macrophage response induced by nonporous and porous silica nanoparticles. Nanomedicine, 14(2), 533-545.
  6. Brady SW, McQuerry JA, Qiao Y, Piccolo SR, Shrestha G, Jenkins DF, Layer RM, Pedersen BS, Miller RH, Esch A, Selitsky SR, Parker JS, Anderson LA, Dalley BK, Factor RE, Reddy CB, Boltax JP, Li DY, Moos PJ, Gray JW, Heiser LM, Buys SS, Cohen AL, Johnson WE, Quinlan AR, Marth G, Werner TL, Bild A (2018). Publisher Correction: Combating subclonal evolution of resistant cancer phenotypes. Nature communications, 9(1), 572.
  7. Brady SW, McQuerry JA, Qiao Y, Piccolo SR, Shrestha G, Jenkins DF, Layer RM, Pedersen BS, Miller RH, Esch A, Selitsky SR, Parker JS, Anderson LA, Dalley BK, Factor RE, Reddy CB, Boltax JP, Li DY, Moos PJ, Gray JW, Heiser LM, Buys SS, Cohen AL, Johnson WE, Quinlan AR, Marth G, Werner TL, Bild A (2017). Combating subclonal evolution of resistant cancer phenotypes. Nature communications, 8(1), 1231.